Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round:
(PYPL) - Get Report : "This stock is down five points. I'd wait a few more points, then buy, buy, buy."
(SENS) - Get Report : "If you want glucose monitoring, I'd go with Abbott Laboratories
(ABT) - Get Report or DexCom
(DXCM) - Get Report ."
(IDXX) - Get Report : "If it comes down, you buy it. Another five points is perfect."
(SONO) - Get Report : "No, no, no. That's not the kind of stock you buy into weakness. "
(DNR) - Get Report : "I think you've had a good run and that group is struggling. ring the register."
(APTI) - Get Report : "I want to buy the cloud kings like Salesforce.com
(CRM) - Get Report . That's a high quality stock."
(NVTA) - Get Report : "This is too speculative for me."
(W) - Get Report : "I never thought it would get to this level so why would you listen to me? I haven't gotten this one right."
(JD) - Get Report : "I'm not a believer in Chinese stocks. "
(MCD) - Get Report : "This stock has been acting terribly. I prefer Wendy's
(WEN) - Get Report ."
Cramer and the AAP team remain bullish on Amgen
(AMGN) - Get Report . Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.
Over on Real Money, Cramer tells us what he thinks of Coca-Cola's
(KO) - Get Report possible move into cannabis. Get more of his insights with a free trial subscription to Real Money.
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
To read a full recap of this episode of "Mad Money," click here.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.
At the time of publication, Cramer's Action Alerts PLUS had a position in AMGN, PYPL, ABT, CRM.